RGEN
NASDAQ
Life Sciences Tools & Services
$147.25
USD
-$1.30 (-0.88%)
At close: Jul 17, 2026, 4:00 PM EDT
Market Cap:
$8.17B
Volume:
912.4K
Previous Close
$148.55
Day Range
$143.88 - $149.06
52 Week Range
$100.99 - $175.77
Average Volume (10 Days)
710.0K
P/E Ratio (TTM)
158.97
Dividend Yield
—
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. The company is headquartered in Waltham, Massachusetts and currently employs 2,000 full-time employees. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
CEO
Mr. Olivier Loeillot
Headquaters
Waltham, MASSACHUSETTS, US
Founded
1986
Employees
2,000
SHC
Sotera Health Co
$17.75
-2.9%